AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Journal of Neurorestoratology Article
PDF (684 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review Article | Open Access

The cell repair research of spinal cord injury: a review of cell transplantation to treat spinal cord injury

Zhenrong Zhang1, Fangyong Wang1,2( ), Mingjie Song1
School of Rehabilitation, Capital Medical University, Beijing 100068, China
Department of Spine and Spinal Cord Surgery, Beijing Bo’ai Hospital, China Rehabilitation Research Center, Beijing 100068, China
Show Author Information

Abstract

Through retrospective analysis of the literature on the cell repair of spinal cord injury worldwide, it is found that the mechanism of cell transplantation repairing spinal cord injury is mainly to replace damaged neurons, protect host neurons, prevent apoptosis, promote axonal regeneration and synapse formation, promote myelination, and secrete trophic factors or growth factors to improve microenvironment. A variety of cells are used to repair spinal cord injury. Stem cells include multipotent stem cells, embryonic stem cells, and induced pluripotent stem cells. The multipotent stem cells are mainly various types of mesenchymal stem cells and neural stem cells. Non-stem cells include olfactory ensheathing cells and Schwann cells. Transplantation of inhibitory interneurons to alleviate neuropathic pain in patients is receiving widespread attention. Different types of cell transplantation have their own advantages and disadvantages, and multiple cell transplantation may be more helpful to the patient’s functional recovery. These cells have certain effects on the recovery of neurological function and the improvement of complications, but further exploration is needed in clinical application. The application of a variety of cell transplantation, gene technology, bioengineering and other technologies has made the prospect of cell transplantation more extensive. There is a need to find a safe and effective comprehensive treatment to maximize and restore the patient’s performance.

Keywords

cell transplantationspinal cord injury (SCI)nerve repair

References

[1]
Jazayeri SB, Beygi S, Shokraneh F, et al. Incidence of traumatic spinal cord injury worldwide: a systematic review. Eur Spine J. 2015, 24(5): 905-918.
Crossref Google Scholar
[2]
Kang Y, Ding H, Zhou HX, et al. Epidemiology of worldwide spinal cord injury: a literature review. J Neurorestoratology. 2017, 6: 1-9.
Crossref Google Scholar
[3]
Yang R, Guo L, Wang P, et al. Epidemiology of spinal cord injuries and risk factors for complete injuries in Guangdong, China: a retrospective study. PLoS One. 2014, 9(1): e84733.
Crossref Google Scholar
[4]
Burt AA. (iii) The epidemiology, natural history and prognosis of spinal cord injury. Curr Orthop. 2004, 18(1): 26-32.
Crossref Google Scholar
[5]
Kumar R, Lim J, Mekary RA, et al. Traumatic spinal injury: global epidemiology and worldwide volume. World Neurosurg. 2018, 113: e345-e363.
Crossref Google Scholar
[6]
Ackery A, Tator C, Krassioukov A. A global perspective on spinal cord injury epidemiology. J Neurotrauma. 2004, 21(10): 1355-1370.
Crossref Google Scholar
[7]
Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg. 1991, 75(1): 15-26.
Crossref Google Scholar
[8]
Shende P, Subedi M. Pathophysiology, mechanisms and applications of mesenchymal stem cells for the treatment of spinal cord injury. Biomed Pharmacother. 2017, 91: 693-706.
Crossref Google Scholar
[9]
Forostyak S, Jendelova P, Sykova E. The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications. Biochimie. 2013, 95(12): 2257-2270.
Crossref Google Scholar
[10]
Kim YH, Ha KY, Kim SI. Spinal cord injury and related clinical trials. Clin Orthop Surg. 2017, 9(1): 1.
Crossref Google Scholar
[11]
Oliveri RS, Bello S, Biering-Sørensen F. Mesenchymal stem cells improve locomotor recovery in traumatic spinal cord injury: systematic review with meta-analyses of rat models. Neurobiol Dis. 2014, 62: 338-353.
Crossref Google Scholar
[12]
Llewellyn-Smith IJ, Basbaum AI, Bráz JM. Long-term, dynamic synaptic reorganization after GABAergic precursor cell transplantation into adult mouse spinal cord. J Comp Neurol. 2018, 526(3): 480-495.
Crossref Google Scholar
[13]
Lu P, Woodruff G, Wang YZ, et al. Long-distance axonal growth from human induced pluripotent stem cells after spinal cord injury. Neuron. 2014, 83(4): 789-796.
Crossref Google Scholar
[14]
Lin XY, Lai BQ, Zeng X, et al. Cell transplantation and neuroengineering approach for spinal cord injury treatment: A summary of current laboratory findings and review of literature. Cell Transplant. 2016, 25(8): 1425-1438.
Crossref Google Scholar
[15]
Iyer NR, Wilems TS, Sakiyama-Elbert SE. Stem cells for spinal cord injury: Strategies to inform differentiation and transplantation. Biotechnol Bioeng. 2017, 114(2): 245-259.
Crossref Google Scholar
[16]
Wu GH, Shi HJ, Che MT, et al. Recovery of paralyzed limb motor function in canine with complete spinal cord injury following implantation of MSC-derived neural network tissue. Biomaterials. 2018, 181: 15-34.
Crossref Google Scholar
[17]
Zhou ZL, Zhang H, Jin AM, et al. A combination of taxol infusion and human umbilical cord mesenchymal stem cells transplantation for the treatment of rat spinal cord injury. Brain Res. 2012, 1481: 79-89.
Crossref Google Scholar
[18]
Shahrezaie M, Mansour RN, Nazari B, et al. Improved stem cell therapy of spinal cord injury using GDNF-overexpressed bone marrow stem cells in a rat model. Biologicals. 2017, 50: 73-80.
Crossref Google Scholar
[19]
Nejati-Koshki K, Mortazavi Y, Pilehvar-Soltanahmadi Y, et al. An update on application of nanotechnology and stem cells in spinal cord injury regeneration. Biomed Pharmacother. 2017, 90: 85-92.
Crossref Google Scholar
[20]
Jung DI, Ha J, Kang BT, et al. A comparison of autologous and allogenic bone marrow-derived mesenchymal stem cell transplantation in canine spinal cord injury. J Neurol Sci. 2009, 285(1/2): 67-77.
Crossref Google Scholar
[21]
Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the first 25 years and beyond. Blood. 2013, 122(4): 491-498.
Crossref Google Scholar
[22]
Bai LP, Li DT, Li J, et al. Bioactive molecules derived from umbilical cord mesenchymal stem cells. Acta Histochem. 2016, 118(8): 761-769.
Crossref Google Scholar
[23]
Kern S, Eichler H, Stoeve J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006, 24(5): 1294-1301.
Crossref Google Scholar
[24]
Borghesi J, Ferreira Lima M, Mario LC, et al. Canine amniotic membrane mesenchymal stromal/stem cells: Isolation, characterization and differentiation. Tissue Cell. 2019, 58: 99-106.
Crossref Google Scholar
[25]
Ohta Y, Hamaguchi A, Ootaki M, et al. Intravenous infusion of adipose-derived stem/stromal cells improves functional recovery of rats with spinal cord injury. Cytotherapy. 2017, 19(7): 839-848.
Crossref Google Scholar
[26]
Hur JW, Cho TH, Park DH, et al. Intrathecal transplantation of autologous adipose-derived mesenchymal stem cells for treating spinal cord injury: A human trial. J Spinal Cord Med. 2016, 39(6): 655-664.
Crossref Google Scholar
[27]
Wu B, Sun L, Li PJ, et al. Transplantation of oligodendrocyte precursor cells improves myelination and promotes functional recovery after spinal cord injury. Injury. 2012, 43(6): 794-801.
Crossref Google Scholar
[28]
Li N, Leung GK. Oligodendrocyte precursor cells in spinal cord injury: A review and update. Biomed Res Int. 2015, 2015: 235195.
Crossref Google Scholar
[29]
Priest CA, Manley NC, Denham J, et al. Preclinical safety of human embryonic stem cell-derived oligodendrocyte progenitors supporting clinical trials in spinal cord injury. Regen Med. 2015, 10(8): 939-958.
Crossref Google Scholar
[30]
Kumamaru H, Saiwai H, Kubota K, et al. Therapeutic activities of engrafted neural stem/precursor cells are not dormant in the chronically injured spinal cord. Stem Cells. 2013, 31(8): 1535-1547.
Crossref Google Scholar
[31]
Cheng I, Githens M, Smith RL, et al. Local versus distal transplantation of human neural stem cells following chronic spinal cord injury. Spine J. 2016, 16(6): 764-769.
Crossref Google Scholar
[32]
Curtis E, Martin JR, Gabel B, et al. A first-in-human, phase I study of neural stem cell transplantation for chronic spinal cord injury. Cell Stem Cell. 2018, 22(6): 941-950.e6.
Crossref Google Scholar
[33]
Ilic D, Devito L, Miere C, et al. Human embryonic and induced pluripotent stem cells in clinical trials. Br Med Bull. 2015, 116: 19-27.
Crossref Google Scholar
[34]
Vismara I, Papa S, Rossi F, et al. Current options for cell therapy in spinal cord injury. Trends Mol Med. 2017, 23(9): 831-849.
Crossref Google Scholar
[35]
Goulão M, Lepore AC. IPS cell transplantation for traumatic spinal cord injury. CSCR. 2016, 11(4): 321-328.
Crossref Google Scholar
[36]
Young W. Spinal cord regeneration. Cell Transplant. 2014, 23(4/5): 573-611.
Crossref Google Scholar
[37]
Qin C, Guo Y, Yang DG, et al. Induced pluripotent stem cell transplantation improves locomotor recovery in rat models of spinal cord injury: a systematic review and meta-analysis of randomized controlled trials. Cell Physiol Biochem. 2018, 47(5): 1835-1852.
Crossref Google Scholar
[38]
Doulames VM, Plant GW. Induced pluripotent stem cell therapies for cervical spinal cord injury. Int J Mol Sci. 2016, 17(4): 530.
Crossref Google Scholar
[39]
Zhong WT, Bian KP, Hu YN, et al. Lysophosphatidic acid guides the homing of transplanted olfactory ensheathing cells to the lesion site after spinal cord injury in rats. Exp Cell Res. 2019, 379(1): 65-72.
Crossref Google Scholar
[40]
Chen L, Zhang Y, He X, et al. Comparison of intramedullary transplantation of olfactory ensheathing cell for patients with chronic complete spinal cord injury worldwide. J Neurorestoratology. 2018, 1(6):146-151.
Crossref Google Scholar
[41]
Zheng ZC, Du XJ, Zhang KG, et al. Olfactory ensheathing cell transplantation inhibits P2X4 receptor overexpression in spinal cord injury rats with neuropathic pain. Neurosci Lett. 2017, 651: 171-176.
Crossref Google Scholar
[42]
Hosseini M, Yousefifard M, Baikpour M, et al. The efficacy of Schwann cell transplantation on motor function recovery after spinal cord injuries in animal models: A systematic review and meta-analysis. J Chem Neuroanat. 2016, 78: 102-111.
Crossref Google Scholar
[43]
Anderson KD, Guest JD, Dietrich WD, et al. Safety of autologous human schwann cell transplantation in subacute thoracic spinal cord injury. J Neurotrauma. 2017, 34(21): 2950-2963.
Crossref Google Scholar
[44]
Chen XM, Xue BH, Li YP, et al. Meta-analysis of stem cell transplantation for reflex hypersensitivity after spinal cord injury. Neuroscience. 2017, 363: 66-75.
Crossref Google Scholar
[45]
Fandel TM, Trivedi A, Nicholas CR, et al. Transplanted human stem cell-derived interneuron precursors mitigate mouse bladder dysfunction and central neuropathic pain after spinal cord injury. Cell Stem Cell. 2016, 19(4): 544-557.
Crossref Google Scholar
[46]
Blesch A. Human ESC-derived interneurons improve major consequences of spinal cord injury. Cell Stem Cell. 2016, 19(4): 423-424.
Crossref Google Scholar
[47]
Marín O. Cellular and molecular mechanisms controlling the migration of neocortical interneurons. Eur J Neurosci. 2013, 38(1): 2019-2029.
Crossref Google Scholar
[48]
Etlin A, Bráz JM, Kuhn JA, et al. Functional synaptic integration of forebrain GABAergic precursors into the adult spinal cord. J Neurosci. 2016, 36(46): 11634-11645.
Crossref Google Scholar
[49]
Bráz JM, Sharif-Naeini R, Vogt D, et al. Forebrain GABAergic neuron precursors integrate into adult spinal cord and reduce injury-induced neuropathic pain. Neuron. 2012, 74(4): 663-675.
Crossref Google Scholar
[50]
Wei GJ, An G, Shi ZW, et al. Suppression of MicroRNA-383 enhances therapeutic potential of human bone-marrow- derived mesenchymal stem cells in treating spinal cord injury via GDNF. Cell Physiol Biochem. 2017, 41(4): 1435-1444.
Crossref Google Scholar
[51]
Stewart AN, Kendziorski G, Deak ZM, et al. Transplantation of mesenchymal stem cells that overexpress NT-3 produce motor improvements without axonal regeneration following complete spinal cord transections in rats. Brain Res. 2018, 1699: 19-33.
Crossref Google Scholar
[52]
Shang AJ, Hong SQ, Xu Q, et al. NT-3-secreting human umbilical cord mesenchymal stromal cell transplantation for the treatment of acute spinal cord injury in rats. Brain Res. 2011, 1391: 102-113.
Crossref Google Scholar
[53]
Ye Y, Feng TT, Peng YR, et al. The treatment of spinal cord injury in rats using bone marrow-derived neural-like cells induced by cerebrospinal fluid. Neurosci Lett. 2018, 666: 85-91.
Crossref Google Scholar
[54]
Galhom RA, Hussein Abd El Raouf HH, Mohammed Ali MH. Role of bone marrow derived mesenchymal stromal cells and Schwann-like cells transplantation on spinal cord injury in adult male albino rats. Biomed Pharmacother. 2018, 108: 1365-1375.
Crossref Google Scholar
[55]
Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003, 302(5644): 415-419.
Crossref Google Scholar
[56]
Muheremu A, Peng J, Ao Q. Stem cell based therapies for spinal cord injury. Tissue Cell. 2016, 48(4): 328-333.
Crossref Google Scholar
[57]
Agbay A, Edgar JM, Robinson M, et al. Biomaterial strategies for delivering stem cells as a treatment for spinal cord injury. Cells Tissues Organs (Print). 2016, 202(1/2): 42-51.
Crossref Google Scholar
[58]
Li XR, Fan CX, Xiao ZF, et al. A collagen microchannel scaffold carrying paclitaxel-liposomes induces neuronal differentiation of neural stem cells through Wnt/β-catenin signaling for spinal cord injury repair. Biomaterials. 2018, 183: 114-127.
Crossref Google Scholar
[59]
Koffler J, Zhu W, Qu X, et al. Biomimetic 3D-printed scaffolds for spinal cord injury repair. Nat Med. 2019, 25(2): 263-269.
Crossref Google Scholar
[60]
Xie XM, Shi LL, Shen L, et al. Co-transplantation of MRF- overexpressing oligodendrocyte precursor cells and Schwann cells promotes recovery in rat after spinal cord injury. Neurobiol Dis. 2016, 94: 196-204.
Crossref Google Scholar
[61]
Elboghdady I, Hassanzadeh H, Stein BE, et al. Controversies and potential risk of mesenchymal stem cells application. Semin Spine Surg. 2015, 27(2): 103-106.
Crossref Google Scholar
[62]
Huang HY, Sharma HS, Chen L, et al. 2018 Yearbook of Neurorestoratology. J Neurorestroratology. 2019, 1(7): 8-17.
Crossref Google Scholar
[63]
Huang HY, Shanker S H, Lin C, et al. Review of clinical neurorestorative strategies for spinal cord injury: exploring history and latest progresses. J Neurorestroratology. 2018, 1(6): 171-178.
Crossref Google Scholar
[64]
Baastrup C, Maersk-Moller CC, Nyengaard JR, et al. Spinal-, brainstem- and cerebrally mediated responses at- and below- level of a spinal cord contusion in rats: evaluation of pain-Like behavior. Pain. 2010, 151(3): 670-679.
Crossref Google Scholar
Journal of Neurorestoratology
Volume 7 Issue 2,
June 2019
Pages 55-62
DOI: 10.26599/JNR.2019.9040011
Cite this article:
Zhang Z, Wang F, Song M. The cell repair research of spinal cord injury: a review of cell transplantation to treat spinal cord injury. Journal of Neurorestoratology, 2019, 7(2): 55-62. https://doi.org/10.26599/JNR.2019.9040011

997

Views

81

Downloads

21

Crossref

22

Web of Science

0

Scopus

Altmetrics
Received: 03 June 2019
Revised: 26 June 2019
Accepted: 27 June 2019
Published: 22 July 2019
© The authors 2019

This article is published with open access at http://jnr.tsinghuajournals.com
Return